Sarepta 治療公司
MX ˙ BMV ˙ US8036071004
SecurityMX:SRPT / Sarepta Therapeutics, Inc.
InstitutionCapital Fund Management S.a.
Latest Disclosed Ownership459,322 shares
Latest Disclosed Value $ 9,994,846
Capital Fund Management S.a. ownership in SRPT / Sarepta Therapeutics, Inc.

On May 14, 2026 - Capital Fund Management S.a. filed a 13F-HR form disclosing ownership of 459,322 shares of Sarepta Therapeutics, Inc. (MX:SRPT) valued at $9,994,846 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 485,453 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of -5.38% during the quarter.

Capital Fund Management S.a. has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options. The firm currently holds call options representing 65,000 of underlying shares valued at $1,414,400 USD and put options representing 18,900 of underlying shares valued at $411,264 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F SAREPTA THERAPEUTICS INC COM SAREPTA THERAPEUTICS INC COM 803607100 459,322 -26,131 -5.38 9,995 -4.33 0.0452
2026-02-17 2025-12-31 13F SAREPTA THERAPEUTICS INC COM SAREPTA THERAPEUTICS INC COM 803607100 485,453 -294,601 -37.77 10,447 -30.50 0.0290
2025-11-13 2025-09-30 13F SAREPTA THERAPEUTICS COM 803607100 780,054 265,309 51.54 15,032 70.77 0.0394
2025-08-13 2025-06-30 13F SAREPTA THERAPEUTICS COM 803607100 514,745 314,608 157.20 8,802 -31.08 0.0242
2025-05-14 2025-03-31 13F SAREPTA THERAPEUTICS COM 803607100 200,137 26,392 15.19 12,773 -39.54 0.0368
2025-02-13 2024-12-31 13F SAREPTA THERAPEUTICS COM 803607100 173,745 -30,401 -14.89 21,126 -17.14 0.0539
2024-11-13 2024-09-30 13F SAREPTA THERAPEUTICS COM 803607100 204,146 204,146 25,496 0.0698
2024-08-13 2024-06-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -39,881 -100.00 0 -100.00
2024-05-15 2024-03-31 13F SAREPTA THERAPEUTICS COM 803607100 39,881 -35,815 -47.31 5,163 -29.28 0.0149
2024-02-14 2023-12-31 13F SAREPTA THERAPEUTICS COM 803607100 75,696 75,696 7,299 0.0196
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -15,028 -100.00 0 -100.00
2022-08-12 2022-06-30 13F SAREPTA THERAPEUTICS COM 803607100 15,028 -20,855 -58.12 1,126 -59.83 0.0102
2022-05-12 2022-03-31 13F SAREPTA THERAPEUTICS COM 803607100 35,883 18,471 106.08 2,803 78.88 0.0229
2022-02-10 2021-12-31 13F SAREPTA THERAPEUTICS COM 803607100 17,412 17,412 1,568 0.0113
2020-08-13 2020-06-30 13F Sarepta Therapeutics COM 803607100 0 -9,923 -100.00 0 -100.00
2020-05-13 2020-03-31 13F Sarepta Therapeutics COM 803607100 9,923 -2,021 -16.92 971 -36.99 0.0150
2020-02-13 2019-12-31 13F Sarepta Therapeutics COM 803607100 11,944 11,944 1,541 0.0121
2019-11-13 2019-09-30 13F Sarepta Therapeutics COM 803607100 0 -7,405 -100.00 0 -100.00
2019-08-12 2019-06-30 13F Sarepta Therapeutics COM 803607100 7,405 5,583 306.42 1,125 418.43 0.0102
2019-05-13 2019-03-31 13F/A-1 Sarepta Therapeutics COM 803607100 1,822 1,822 217 0.0019
2018-11-14 2018-09-30 13F Sarepta Therapeutics COM 803607100 0 -48,040 -100.00 0 -100.00
2018-08-14 2018-06-30 13F Sarepta Therapeutics COM 803607100 48,040 15,842 49.20 6,350 166.14 0.0331
2018-05-15 2018-03-31 13F Sarepta Therapeutics COM 803607100 32,198 -38,938 -54.74 2,386 -39.72 0.0143
2018-02-09 2017-12-31 13F Sarepta Therapeutics COM 803607100 71,136 65,738 1,217.82 3,958 1,515.51 0.0218
2017-11-13 2017-09-30 13F Sarepta Therapeutics COM 803607100 5,398 5,398 245 0.0018
2017-08-10 2017-06-30 13F Sarepta Therapeutics COM 803607100 0 -223,101 -100.00 0 -100.00
2017-05-03 2017-03-31 13F Sarepta Therapeutics COM 803607100 223,101 223,101 6,604 0.0551
2016-05-02 2016-03-31 13F Sarepta Therapeutics COM 803607100 0 -56,694 -100.00 0 -100.00
2016-01-28 2015-12-31 13F Sarepta Therapeutics COM 803607100 56,694 14,707 35.03 2,187 62.24 0.0225
2015-10-27 2015-09-30 13F Sarepta Therapeutics COM 803607100 41,987 41,987 1,348 0.0151
2015-07-28 2015-06-30 13F Sarepta Therapeutics COM 803607100 0 -24,730 -100.00 0 -100.00
2015-04-28 2015-03-31 13F Sarepta Therapeutics COM 803607100 24,730 24,730 328 0.0045
2015-01-28 2014-12-31 13F Sarepta Therapeutics COM 803607100 0 -27,440 -100.00 0 -100.00
2014-10-31 2014-09-30 13F Sarepta Therapeutics COM 803607100 27,440 -342,096 -92.57 579 -92.31 0.0065
2014-01-31 2013-12-31 13F Sarepta Therapeutics COM 803607100 369,536 271,948 278.67 7,527 63.31 0.0931
2013-10-31 2013-09-30 13F Sarepta Therapeutics COM 803607100 97,588 97,588 4,609 0.0637
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F SAREPTA THERAPEUTICS INC COM SAREPTA THERAPEUTICS INC COM Call 65,000 -57.52 1,414 -57.05 n/a n/a n/a
2026-02-17 2025-12-31 13F SAREPTA THERAPEUTICS INC COM SAREPTA THERAPEUTICS INC COM Call 153,000 -33.56 3,293 -25.81 n/a n/a n/a
2025-11-13 2025-09-30 13F SAREPTA THERAPEUTICS COM Call 230,300 272.05 4,438 319.38 n/a n/a n/a
2025-08-13 2025-06-30 13F SAREPTA THERAPEUTICS COM Call 61,900 1,058 n/a n/a n/a
2020-05-13 2020-03-31 13F Sarepta Therapeutics COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-13 2019-12-31 13F Sarepta Therapeutics COM Call 14,000 3.70 1,807 77.68 n/a n/a n/a
2019-11-13 2019-09-30 13F Sarepta Therapeutics COM Call 13,500 0.00 1,017 -50.41 n/a n/a n/a
2019-08-12 2019-06-30 13F Sarepta Therapeutics COM Call 13,500 0.00 2,051 27.47 n/a n/a n/a
2019-05-13 2019-03-31 13F/A Sarepta Therapeutics COM Call 13,500 -73.32 1,609 -70.86 n/a n/a n/a
2019-05-13 2019-03-31 13F Sarepta Therapeutics COM Call 50,600 5,522 n/a n/a n/a
2019-02-13 2018-12-31 13F Sarepta Therapeutics COM Call 50,600 -11.85 5,522 -40.44 n/a n/a n/a
2018-11-14 2018-09-30 13F Sarepta Therapeutics COM Call 57,400 825.81 9,271 1,030.61 n/a n/a n/a
2018-08-14 2018-06-30 13F Sarepta Therapeutics COM Call 6,200 14.81 820 105.00 n/a n/a n/a
2018-05-15 2018-03-31 13F Sarepta Therapeutics COM Call 5,400 -31.65 400 -9.09 n/a n/a n/a
2018-02-09 2017-12-31 13F Sarepta Therapeutics COM Call 7,900 -40.60 440 -27.03 n/a n/a n/a
2017-11-13 2017-09-30 13F Sarepta Therapeutics COM Call 13,300 -16.88 603 11.87 n/a n/a n/a
2017-08-10 2017-06-30 13F Sarepta Therapeutics COM Call 16,000 -76.88 539 -73.68 n/a n/a n/a
2017-05-03 2017-03-31 13F Sarepta Therapeutics COM Call 69,200 743.90 2,048 429.20 n/a n/a n/a
2014-01-31 2013-12-31 13F Sarepta Therapeutics COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2013-10-31 2013-09-30 13F Sarepta Therapeutics COM Call 8,200 387 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F SAREPTA THERAPEUTICS INC COM SAREPTA THERAPEUTICS INC COM Put 18,900 -83.23 411 -83.05 n/a n/a n/a
2026-02-17 2025-12-31 13F SAREPTA THERAPEUTICS INC COM SAREPTA THERAPEUTICS INC COM Put 112,700 -17.31 2,425 -7.65 n/a n/a n/a
2025-11-13 2025-09-30 13F SAREPTA THERAPEUTICS COM Put 136,300 205.61 2,627 244.62 n/a n/a n/a
2025-08-13 2025-06-30 13F SAREPTA THERAPEUTICS COM Put 44,600 763 n/a n/a n/a
2019-08-12 2019-06-30 13F Sarepta Therapeutics COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-13 2019-03-31 13F Sarepta Therapeutics COM Put 13,900 0.00 1,517 0.00 n/a n/a n/a
2019-02-13 2018-12-31 13F Sarepta Therapeutics COM Put 13,900 -57.36 1,517 -71.19 n/a n/a n/a
2018-11-14 2018-09-30 13F Sarepta Therapeutics COM Put 32,600 307.50 5,265 398.11 n/a n/a n/a
2018-08-14 2018-06-30 13F Sarepta Therapeutics COM Put 8,000 -12.09 1,057 145.81 n/a n/a n/a
2014-01-31 2013-12-31 13F Sarepta Therapeutics COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2013-10-31 2013-09-30 13F Sarepta Therapeutics COM Put 9,100 430 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.